In an increasingly interconnected world, the transfer of technology between different stakeholders and across borders is becoming an integral process in many industries, including pharma
In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.
As the world and the UK continues its march out of the pandemic’s shadow, the pharmaceutical and life sciences sector has been squarely in the spotlight.
MSD has been rumoured to be considering a takeover of Viking Therapeutics in order to get a horse in the obesity therapy race but chose instead to back a runner from China's Hansh Pharma.